Kindbody, a fertility clinic network and family-building benefits provider for employers, announced the launch of Kindlabs, its in-house genetic testing division. The addition of Kindlabs incorporates genomics into the company’s vertically integrated, end-to-end model, delivering a seamless continuum of care to Kindbody patients. Kindlabs operates its 8,000-square-foot state-of-the-art reference laboratory in Secaucus, NJ, under the leadership of Dr Amber Cooper, Kindbody’s chief medical officer of Genomics and Laboratory Sciences, and Manuel Viotti, PhD, HCLD, vice president of Preimplantation Genetic Testing (PGT) and clinical laboratory director.

“At the heart of Kindbody’s mission is to help build healthy families for our patients,” says Dr Angeline Beltsos, CEO, Clinical, at Kindbody. “The addition of Kindlabs combines industry-leading technology and expertise, and stringent quality standards, to optimize our patients’ chances of achieving a successful pregnancy and bringing home a healthy baby.”

Further Reading: Unlocking the Secrets of Ovarian Reserve and Anti-Mullerian Hormone

Kindlabs offers a verticalized genetic testing platform, from wet lab chemistry to software and bioinformatics, providing comprehensive, medical-grade genetic tests at price points that help to democratize access to genomic information. Kindlabs is certified by the Clinical Laboratory Improvement Amendments (CLIA) and is enrolled in the accreditation program of the College of American Pathologists (CAP), which is widely recognized as the gold standard for molecular diagnostics, ensuring the most accurate and reliable results. Prior to the launch of Kindlabs, Kindbody outsourced preimplantation genetic testing.

“Under the visionary leadership of Dr Viotti, our dedicated scientific team has made significant strides in advancing genomic sequencing analysis for the benefit of patients,” says Cooper. “Dr Viotti’s instrumental role in spearheading the development of Kindlabs has positioned Kindbody as leaders in the industry. Together, our team is revolutionizing genomic analysis, delivering valuable improvements that positively impact patients’ lives.”

Kindbody’s clinically managed program covers the full spectrum of reproductive health, including both female and male fertility, which encompasses fertility assessments and education, fertility preservation, genetic testing, in vitro fertilization (IVF), donor and surrogacy services, and adoption, as well as a full continuum of reproductive care including physical, mental, and emotional support.

Kindbody owns and operates 32 signature clinics throughout the U.S. in Arkansas, California, Colorado, District of Columbia, Georgia, Illinois, Maryland, Michigan, Missouri, New Jersey, New York, Texas, Washington, and Wisconsin.